New Brunswick, N.J.-based Johnson & Johnson launched a new program to avoid executive burnout focused on boosting the health and personal care of senior executives.
Research and Markets launched the Johnson & Johnson market research portal, which will offer access to Johnson & Johnson company research.
Cambridge, Mass.-based InVivo Therapeutics enrolled another patient in its INSPIRE study of the Neuro-Spinal Scaffold for spinal cord injury, and the patient is the seventh out of 11 patients who reported an AIS grade improvement at the one-month follow-up after the procedure.
Bordeaux, France-based Implanet’s 2016 revenue grew 18 percent over 2015.
Walnut Creek, Calif.-based Providence Medical Technology earned FDA clearance for its CAVUX Cervical Cage-L System and ALLY Facet Screws.
San Diego-based NuVasive announced FDA clearance of its CoRoent Small Interbody System for up to four contiguous levels.
Toronto Western Hospital represents the first Canadian site for Cambridge, Mass.-based InVivo Therapeutics’ cervical spinal cord injury study.
New Brunswick, N.J.-based DePuy Synthes launched the ATTUNE Revision Fixed Bearing Tibial Base and the 14mm by 50 mm Cemented Stem.
A study found that DePuy Synthes’ ATTUNE Knee’s estimated cumulative percent revision was 1.39 percent at three years, translating to a 98.61 percent survivorship rate.
DePuy Synthes Mitek Sports Medicine released a new suite of arthroscopic devices.
Aliso Viejo, Calif.-based OrthAlign announced the completion of the 60,000th joint arthroplasty case using the medical device company’s technology.
Plainsboro, N.J.-based Integra LifeSciences announced full commercial availability of its Cadence Total Ankle system.
Integra LifeSciences’ partnership with India-based Dr. Reddy’s Laboratories will expand the device company’s global market.
Canton, Mass.-based Organogenesis acquired Birmingham, Ala.-based NuTech Medical to tap in to the profitable orthopedic and spine tissue product market.
Boise, Idaho-based Burst Biologics will begin a study involving spinal fusion patients.
More articles on devices:
U.S. spinal implant & vertebral compression fracture market to reach $7B — 5 insights
FDA clears 1st cervical cage for use in 4 contiguous levels — 5 details
OrthAlign device used in 60,000th joint arthroplasty case — 4 takeaways
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
